TIP819: Lifco AB (LIFCO-B.ST): The Serial Acquirer Building an Unstoppable Compounding Engine w/ Kyle Grieve & Shawn O'Malley

What It Covers

Kyle Grieve and Shawn O'Malley analyze Lifco AB, a Swedish serial acquirer with 275+ acquisitions across dental, demolition robotics, and industrial niches. Since its 2014 IPO, Lifco has compounded earnings at 14% annually, grown free cash flow at 23% CAGR, and never diluted shareholders, making it a candidate for their intrinsic value portfolio.

Key Questions Answered

• •Serial Acquirer Arbitrage: Lifco purchases niche private businesses at roughly 7x EBITDA, but those same businesses are immediately revalued at Lifco's public market multiple of ~18x EBITDA. A €17M revenue business bought for ~€27M becomes worth ~€70M upon acquisition. Investors should understand this re-rating mechanism drives a significant portion of returns, separate from operational improvement or organic growth.
• •Put-Call Option Structure: Rather than earnouts or dilutive equity, Lifco uses put-call options covering 14–17% of deal value to retain minority sellers. Sellers hold a put option to sell remaining shares at a price tied to future earnings, aligning their incentives with Lifco's performance. Options mature over two to five years and are settled in cash or debt, never new shares.
• •Niche Market Defense: Lifco targets businesses with TAMs in the tens of millions, not billions. A competitor generating $2B in revenue has no rational incentive to capture a $40M niche market, even if technically capable. This dynamic creates durable micro-monopolies. Investors screening for moats should look beyond traditional frameworks and evaluate whether a business occupies a market too small for large competitors to bother entering.
• •CEO Capital Allocation Test: Applying Buffett's "rule of one," Per Waldemarsson has allocated ~12.7B SEK since becoming CEO in 2019. Over that period, market cap increased ~75B SEK and dividends totaled ~6B SEK, producing 6.4 SEK of value per 1 SEK retained. This ratio well exceeds the minimum threshold of 1:1, providing a concrete, quantifiable way to evaluate management's capital allocation track record.
• •Dividend Policy as Compounding Drag: Lifco distributes 30–50% of after-tax profit as dividends, with a 33% payout ratio in 2025. Given its active acquisition pipeline and use of debt to fund deals, retaining this capital would reduce leverage and financing costs. Investors evaluating serial acquirers should flag dividend policies as a potential drag on compounding, particularly when the business has high-return reinvestment opportunities available.
• •Segment Volatility Divergence: Since IPO, dental revenue has compounded at 6% with stable ~20% EBITDA margins, while demolition and tools compounded at ~16% but carries the highest cyclicality, tied to construction and infrastructure CapEx cycles. System solutions compounded at ~18% with 29% EBITDA CAGR. Investors should weight segment exposure when assessing downside risk, as macro weakness hits demolition disproportionately while dental provides ballast.